Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt

References

• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951. doi:10.1038/nrmicro178918007677
   PubMed Web of Science ®Google Scholar
• Parte AC. LPSN - list of prokaryotic names with standing in nomenclature (bacterio.net), 20 years on. Int J Syst Evol Microbiol. 2018;68(6):1825–1829. doi:10.1099/ijsem.0.00278629724269
   PubMed Web of Science ®Google Scholar
• Visca P, Seifert H, Towner KJ. Acinetobacter infection - an emerging threat to human health. IUBMB Life. 2011;63(12):1048–1054. doi:10.1002/iub.53422006724
   PubMed Web of Science ®Google Scholar
• Pogue JM, Mann T, Barber KE, Kaye KS. Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev Anti Infect Ther. 2013;11(4):383–393. doi:10.1586/eri.13.1423566148
   PubMed Web of Science ®Google Scholar
• Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A. Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates. Jundishapur J Microbiol. 2014;7(10):e11924. doi:10.5812/jjm.1192425632323
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SI, Kim YR, et al. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection. Epidemiol Infect. 2012;140(1):137–145. doi:10.1017/S095026881100074421554783
   PubMed Web of Science ®Google Scholar
• Upadhyay S, Khyriem AB, Bhattacharya P, Bhattacharjee A, Joshi SR. High-level aminoglycoside resistance in Acinetobacter baumannii recovered from Intensive Care Unit patients in Northeastern India. Indian J Med Microbiol. 2018;36(1):43–48. doi:10.4103/ijmm.IJMM_17_22529735825
   PubMed Web of Science ®Google Scholar
• Lin M-F, Liou M-L, Tu -C-C, Yeh H-W, Lan C-Y. Molecular epidemiology of integron-associated antimicrobial gene cassettes in the clinical isolates of Acinetobacter baumanniifrom Northern Taiwan. Ann Lab Med. 2013;33(4):242. doi:10.3343/alm.2013.33.4.24223826559
   PubMed Web of Science ®Google Scholar
• The Aminoglycoside Resistance Study Groups. The most frequently occurring aminoglycoside resistance mechanisms–combined results of surveys in eight regions of the world. J Chemother (Florence, Italy). 1995;7(Suppl 2):17–30.
   PubMed Web of Science ®Google Scholar
• Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev. 1993;57(1):138–163. doi:10.1128/MR.57.1.138-163.19938385262
   PubMedGoogle Scholar
• Lee C-R, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7.
   Web of Science ®Google Scholar
• Forbes BA, Sahm DF, Weissfeld A. Bailey and Scott’s Diagnostic Microbiology. 12th ed. St Louis, MO, USA: Mosby Elsevier; 2007.
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. Wayne, PA, USA: CLSI Supplement M100; Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• biomerieuxdirect.com. AST-GN69 TEST KIT | VITEK 2 Suscept.test. 64 Wells Gram - | Vitek2 AST Cards 64 Wells | Automated: VITEK system | ID/AST Auto | Bacteriology | bioMerieux Clinical USA. n.d.
   Google Scholar
• Humphries RM, Hindler JA, Goldstein EJC. Emerging resistance, new antimicrobial agents    but no tests! The challenge of antimicrobial susceptibility testing in the current US regulatory landscape. Clin Infect Dis. 2016;63(1):83–88. doi:10.1093/cid/ciw20127025822
   PubMed Web of Science ®Google Scholar
• Magiorakos A, Srinivasan A, Carey RB, et al. Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis. 2010;50(12):1611–1616. doi:10.1086/65275920462357
   PubMed Web of Science ®Google Scholar
• Huang H, Chen B, Liu G, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC Infect Dis. 2018;18(1). doi:10.1186/s12879-017-2932-5
   Web of Science ®Google Scholar
• Fournier PE, Richet H, Weinstein RA. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–699. doi:10.1086/50020216447117
   PubMed Web of Science ®Google Scholar
• Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med. 2003;31(10):2478–2482. doi:10.1097/01.CCM.0000089936.09573.F314530754
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005;31(5):649–655. doi:10.1007/s00134-005-2598-015785929
   PubMed Web of Science ®Google Scholar
• Mahbub SL, Brubaker A, Kovacs E. Aging of the innate immune system: an update. Curr Immunol Rev. 2011;7(1):104–115. doi:10.2174/15733951179447418121461315
   PubMedGoogle Scholar
• Allman D, Miller JP. B cell development and receptor diversity during aging. Curr Opin Immunol. 2005;17(5):463–467. doi:10.1016/j.coi.2005.07.00216054808
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Weyand CM. T cell development and receptor diversity during aging. Curr Opin Immunol. 2005;17(5):468–475. doi:10.1016/j.coi.2005.07.02016098723
   PubMed Web of Science ®Google Scholar
• Akers KS, Chaney C, Barsoumian A, et al. Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. J Clin Microbiol. 2010;48(4):1132–1138. doi:10.1128/JCM.02006-0920107089
   PubMed Web of Science ®Google Scholar
• Sheikhalizadeh V, Hasani A, Ahangarzadeh Rezaee M, et al. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii. J Infect Chemother. 2017;23(2):74–79. doi:10.1016/j.jiac.2016.09.01227889248
   PubMed Web of Science ®Google Scholar
• Japoni-Nejad A, Farshad S, van Belkum A, Ghaznavi-Rad E. Novel cassette array in a class 1 integron in clinical isolates of Acinetobacter baumannii from central Iran. Int J Med Microbiol. 2013;303(8):645–650. doi:10.1016/j.ijmm.2013.09.00524161711
   PubMed Web of Science ®Google Scholar
• Sistanizad M, Kouchek M, Miri M, et al. Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a Teaching Hospital. Iran J Pharm Res. 2013;12(3):503–509.24250656
   PubMed Web of Science ®Google Scholar
• Nie L, Lv Y, Yuan M, et al. Genetic basis of high-level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm Sin B. 2014;4(4):295–300. doi:10.1016/j.apsb.2014.06.00426579398
   PubMed Web of Science ®Google Scholar
• Moniri R, Farahani RK, Shajari G, Shirazi MN, Ghasemi A. Molecular epidemiology of aminoglycosides resistance in Acinetobacter Spp. with emergence of multidrug-resistant strains. Iran J Public Health. 2010;39(2):63–68.23113008
   PubMed Web of Science ®Google Scholar
• Tahbaz SV, Azimi L, Lari AR. Characterization of aminoglycoside resistance mechanisms in Acinetobacter baumannii isolates from burn wound colonization. Ann Burns Fire Disasters. 2019;32(2):115–121.31528151
   PubMedGoogle Scholar
• Asadollahi K, Taherikalani M, Maleki A, et al. Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumanniigenotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol Immunol Hung. 2011;58(4):359–370. doi:10.1556/AMicr.58.2011.4.1122207293
   PubMed Web of Science ®Google Scholar
• Farsiani H, Mosavat A, Soleimanpour S, et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J Med Microbiol. 2015;64(7):767–773. doi:10.1099/jmm.0.00009025991693
   PubMed Web of Science ®Google Scholar
• Salimizand H, Zomorodi AR, Mansury D, et al. Diversity of aminoglycoside modifying enzymes and 16S rRNA methylases in Acinetobacter baumannii and Acinetobacter nosocomialis species in Iran; wide distribution of aadA1 and armA. Infect Genet Evol. 2018;66:195–199. doi:10.1016/j.meegid.2018.09.02830292703
   PubMed Web of Science ®Google Scholar
• Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011;52(6):879–891. doi:10.3349/ymj.2011.52.6.87922028150
   PubMed Web of Science ®Google Scholar
• Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233–1240. doi:10.1099/jmm.0.45716-015585503
   PubMed Web of Science ®Google Scholar